NEW YORK, Sept. 9, 2016 /PRNewswire/ -- The Law
Offices of Vincent Wong announce
that a class action lawsuit has been commenced in the USDC for the
Southern District of New York on
behalf of investors who purchased Keryx Biopharmaceuticals,
Inc. (NASDAQ: KERX) securities February
25, 2016 and August 1,
2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/keryx-biopharmaceuticals. There
is no cost or obligation to you.
According to the complaint, throughout the Class Period,
Defendants made materially false and/or misleading statements, as
well as failed to disclose material adverse facts about the
Company's business, operations, and prospects. Specifically,
Defendants made false and/or misleading statements and/or failed to
disclose: (1) that the Company was experiencing production-related
difficulties in converting API to finished drug product; (2) that
the issue was resulting in decreased production yields of finished
drug product; (3) that, as a result, the Company would, and did
exhaust its reserve of finished drug product; and (4) that, as a
result of the foregoing, Defendants' statements about Keryx's
business, operations, and prospects, were false and misleading
and/or lacked a reasonable basis.
If you suffered a loss in Keryx Biopharmaceuticals you have
until October 3, 2016 to request that
the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://www.wongesq.com/pslra/keryx-biopharmaceuticals.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigations involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Logo - http://photos.prnewswire.com/prnh/20140904/143045
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/kerx-investor-alert-the-law-offices-of-vincent-wong-reminds-investors-of-a-class-action-involving-keryx-biopharmaceuticals-inc-and-a-lead-plaintiff-deadline-of-october-3-2016-300325483.html
SOURCE The Law Offices of Vincent
Wong